"According to DRID data, HCV antibody prevalence in IDUs has been consistently high and increasing over the last 10 years in Greece. In 2011, prevalence rates ranged between 62.4% and 79.3%, depending on the source of data (Figure 6.4). Compared to 2010, in 2011 HCV infection rates remained stable in data source 1 (national sample), but increased significantly in data sources 2 (national sample) and 3 (Athens sample) (Figure 6.4)."

Source

University Mental Health Research Institute, "2012 National Report (2011 Data) to the EMCDDA by the Reitox National Focal Point: Greece: New Development, Trends and in-depth information on selected issues" (Athens, Greece: UMHRI, 2012), p. 96.
http://www.emcdda.europa.eu/h…
http://www.emcdda.europa.eu/a…